AlphaPrime: Using AI to turbocharge clinical trial processes

Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s

AI can boost clinical trials in 2024. 5 ways it could boost

Avicenna, a strategy for in-silico clinical trials

FDA takes first steps toward new guidance for adaptive medical AI

A Phase 2 Open Label Study to Evaluate the Safety and

EISAI PRESENTS FULL RESULTS OF LECANEMAB PHASE 3 CONFIRMATORY

Harnessing the power of AI in clinical trials - PMLiVE

TechNode

AI can boost clinical trials in 2024. 5 ways it could boost

AI Supercharges Clinical Trials for Faster, Better Outcomes